147 related articles for article (PubMed ID: 15706060)
1. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
Chueh PJ; Wu LY; Morré DM; Morré DJ
Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
[TBL] [Abstract][Full Text] [Related]
2. Catechin-vanilloid synergies with potential clinical applications in cancer.
Morré DM; Morré DJ
Rejuvenation Res; 2006; 9(1):45-55. PubMed ID: 16608395
[TBL] [Abstract][Full Text] [Related]
3. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
Yagiz K; Wu LY; Kuntz CP; James Morré D; Morré DM
J Cell Biochem; 2007 May; 101(2):295-306. PubMed ID: 17115410
[TBL] [Abstract][Full Text] [Related]
4. Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein.
Tang X; Morré DJ; Morré DM
Oncol Res; 2007; 16(12):557-67. PubMed ID: 18351130
[TBL] [Abstract][Full Text] [Related]
5. Is the cancer protective effect correlated with growth inhibitions by green tea (-)-epigallocatechin gallate mediated through an antioxidant mechanism?
Cutter H; Wu LY; Kim C; Morré DJ; Morré DM
Cancer Lett; 2001 Jan; 162(2):149-54. PubMed ID: 11146219
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype.
Yagiz K; Morré DJ; Morré DM
J Nutr Biochem; 2006 Nov; 17(11):750-9. PubMed ID: 16517149
[TBL] [Abstract][Full Text] [Related]
7. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX).
Morré DJ; Morré DM; Sun H; Cooper R; Chang J; Janle EM
Pharmacol Toxicol; 2003 May; 92(5):234-41. PubMed ID: 12753411
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
9. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS).
Morré DJ; Morre DM
Mol Cell Biochem; 2006 Feb; 283(1-2):159-67. PubMed ID: 16444599
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface.
Tang X; Tian Z; Chueh PJ; Chen S; Morré DM; Morré DJ
Biochemistry; 2007 Oct; 46(43):12337-46. PubMed ID: 17924659
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
[TBL] [Abstract][Full Text] [Related]
12. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
13. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
14. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.
Chueh PJ; Kim C; Cho N; Morré DM; Morré DJ
Biochemistry; 2002 Mar; 41(11):3732-41. PubMed ID: 11888291
[TBL] [Abstract][Full Text] [Related]
17. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture.
Morré DJ; Bridge A; Wu LY; Morré DM
Biochem Pharmacol; 2000 Oct; 60(7):937-46. PubMed ID: 10974202
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
19. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
20. Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.
Baatout S; Jacquet P; Derradji H; Ooms D; Michaux A; Mergeay M
Oncol Rep; 2004 Jul; 12(1):159-67. PubMed ID: 15201978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
